Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Long-Term Deferred Tax (2022 - 2025)

Historic Long-Term Deferred Tax for Gyre Therapeutics (GYRE) over the last 6 years, with Q3 2025 value amounting to $6.7 million.

  • Gyre Therapeutics' Long-Term Deferred Tax rose 3009.11% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 3009.11%. This contributed to the annual value of $5.6 million for FY2024, which is 1968.05% up from last year.
  • As of Q3 2025, Gyre Therapeutics' Long-Term Deferred Tax stood at $6.7 million, which was up 3009.11% from $6.1 million recorded in Q2 2025.
  • Gyre Therapeutics' Long-Term Deferred Tax's 5-year high stood at $6.7 million during Q3 2025, with a 5-year trough of $4.1 million in Q4 2022.
  • For the 4-year period, Gyre Therapeutics' Long-Term Deferred Tax averaged around $5.4 million, with its median value being $5.2 million (2024).
  • In the last 5 years, Gyre Therapeutics' Long-Term Deferred Tax surged by 1504.53% in 2023 and then skyrocketed by 3009.11% in 2025.
  • Over the past 4 years, Gyre Therapeutics' Long-Term Deferred Tax (Quarter) stood at $4.1 million in 2022, then rose by 15.05% to $4.7 million in 2023, then increased by 19.68% to $5.6 million in 2024, then rose by 19.49% to $6.7 million in 2025.
  • Its Long-Term Deferred Tax stands at $6.7 million for Q3 2025, versus $6.1 million for Q2 2025 and $5.8 million for Q1 2025.